← back to search

Paul‐Henri Lambert

University of Geneva · CH
Area of research
Immunology · Infectious Diseases · mRNA vaccine adjuvant
Research interest
Research interests include Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, and T-cell and B-cell Immunology.
h-index
23
citations
2,515
works
33
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Vaccination programs for older adults in an era of demographic change
European Geriatric Medicine 2018cited by 58position: middledoi
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
PLoS Pathogens 2015cited by 183position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2018–2018)— · 1 papers (2018–2018)Giuseppe Del Giudice · Novartis (Switzerland)1 papers (2018–2018)— · 1 papers (2015–2015)Sébastien Igonet · Institut Pasteur1 papers (2015–2015)Jörg J. Goronzy · Mayo Clinic1 papers (2018–2018)— · 1 papers (2015–2015)Rami Sommerstein · University of Bern1 papers (2015–2015)Mark P. Connolly · Swansea University1 papers (2018–2018)Jan ter Meulen · Seattle University1 papers (2015–2015)William Schaffner · Vanderbilt University Medical Center1 papers (2018–2018)Claire‐Anne Siegrist · University of Geneva1 papers (2015–2015)— · 1 papers (2018–2018)Johan Flamaing · KU Leuven1 papers (2018–2018)Mélissa M. Remy · University of Bern1 papers (2015–2015)— · 1 papers (2015–2015)Andreas Bergthaler · Austrian Academy of Sciences1 papers (2015–2015)Daniel D. Pinschewer · University of Basel1 papers (2015–2015)Thomas A. Bowden · Centre for Human Genetics1 papers (2015–2015)Edward E. Walsh · University of Rochester1 papers (2018–2018)